User:BrezinaJiri/sandbox

= Medullary thymic epithelial cells = Medullary thymic epithelial cells (mTECs) represent unique stromal cell population of the thymus which plays essential role in the establishment of central tolerance. Therefore mTECs rank among cells relevant for the development of functional mammal immune system.

T cell precursors rise in bone marrow and migrate through the bloodstream to the thymus for further development. During their maturation in the thymus, they undergo a process called V(D)J recombination which conducts the development of T cell receptors (TCR). The mechanism of this stochastic process enables on one hand the generation of vast repertoire of TCRs, however, on the other hand causes also origin of so called "autoreactive T cells" which recognize self antigens via their TCRs. Autoreactive T cells must be eliminated from the body or skewed into the T Regulatory cells (TRegs) lineage to prevent manifestations of autoimmunity. mTECs posses the ability to deal with these autoreactive clones via mediation of the processes of central tolerance, namely clonal deletion or T regulatory cell s selection, respectively.

N.B.: All the bellow cited refferences utilized mouse as a observation model.

Promiscuous gene expression
In 1989, two scientific groups came with the hypothesis that thymus expresses genes which are in the periphery strictly expressed by specific tissues (e.g.: Insulin produced by β cells of the pancreas) to subsequently present these so called "Tissue restricted antigens" (TRAs) from almost all parts of the body to developing T cells in order to test which TCRs recognize self-tissues and can be therefore harmful to the body. It was found, after more than a decade, that this phenomenon is managed specifically by mTECs in the thymus and was named Promiscuous gene expression (PGE).

Autoimmune regulator
The only known driver of PGE is a protein called Autoimmune regulator (Aire) which is also specifically expressed by mTECs and its expression is completely dependent on NF- kappa B signaling pathway. Aire recognizes target genes of TRAs via specific methylation marks and requires about 50 partner molecules for activation of their expression. Moreover, Aire-dependent activation of TRA genes expression is accompanied by formation of DNA double-strand breaks which probably results in very short lifespan of mTECs between 2-3 days.

Mutations of Aire gene in human cause a rare autoimmune disorder called Autoimmune Polyendocrinopathy Candidiasis Ectodermal Distrophy (APECED), which usually manifests in combination with other autoimmune diseases e.g.: Diabetes mellitus type 1. Dysfunction of murine Aire gene results in comparable scenario and therefore is mouse used as the model organism for investigation of APECED.

mTECs in numbers
mTECs as a population are capable to express more than 19000 genes (about 80% of mouse genome) among which approximately 4000 belong to Aire-dependent TRAs. It is important to emphasize that single mTEC expresses about 150 Aire-dependent TRAs and approximately 600 Aire-independent TRAs, indicating that other still unknown PGE regulators exist. Indeed, another protein called Fezf2 was suggested to be the second regulator of PGE.

It was shown that each mTEC expresses stochastically 1-3% of TRA pool ! However, more recent studies discovered stable co-expression patterns between TRA genes which are localized in close proximity, suggesting "order in this stochastic process".

mTECs protect against autoreactive T cells
T cell precursors extravasate from the bloodstream in cortico-medullary junction and they first migrate to the thymic cortex, where they undergo construction of TCRs and subsequently a process called T cell positive selection which is mediated by mTEC-related cells: Cortical thymic epithelial cells (cTECs). This process verifies, whether newly generated TCRs are functional. About 90% of T cells displays badly rearranged TCRs, they can´t reach the positive selection and they die by neglect in the cortex. The rest starts to express CCR7, which is a receptor for mTEC-generated chemokine CCL21, and migrate after concentration gradient to the thymic medulla to encounter mTECs.

Two modes of central tolerance induced by mTECs
mTECs aren´t only mediators of PGE and "factories of TRAs". They also express high levels of MHC II and costimulatory molecules CD80/CD86 and rank among efficient Antigen-presenting cells (APCs). Moreover, they utilize macroautophagy to load self antigens on MHCII molecules ! Thus, mTECs are capable to present self-generated TRAs on their MHC molecules to select potential autoreactive T cells. It was published that mTECs mediate clonal deletion (recessive tolerance), via presentation of TRAs, which leads to the apoptosis of autoreactive T cells , as well as they are competent to skew autoreactive T cells into TRegs, also through the presentation of TRAs, which then migrate to the periphery to protect tissues against autoreactive T cells that occasionally avoid selection processes in the thymus (dominant tolerance).

How mTECs discriminate between these two modes of tolerance? It was shown that prospective TRegs interact with presented TRAs with lower affinity than those which are clonally deleted. Furthermore, it was also revealed that specific TRAs skew autoreactive T cells into TRegs with much higher efficiency than they do in the case of clonal deletion.

Cooperative antigen transfer
mTECs form rare population which is composed of approximately 100000 cells per thymus of 2 week old mice. Thus, there is low probability of encounter between autoreactive T cell and mTEC. Unidirectional Cooperative antigen transfer from mTECs to thymic Dendritic Cells (DCs), which itself can´t express TRAs, extends the network of TRA presentation, enables TRA processing by different microenvironments and increases the probability of encounter between autoreactive T cell and its appropriate self-antigen. Moreover, DCs competently induce both recessive and dominant tolerance as well as mTECs.

In contrast, another seminal study reveals that mTECs itself suffice to establish both recessive and dominant tolerance without help of additional APCs.

mTEC subsets
mTEC population is not homogenous and basically could be subdivided into more numerous population of mTECs which express low number of MHCII and CD80/CD86, namely mTECsLo and smaller population of mTECsHi which express higher amounts of these molecules. PGE regulator Aire is expressed only by part of mTECsHi. However, this claim doesn´t mean that mTECsLo don´t contribute to PGE, mTECsHi, especially that expressing Aire, are just much more efficient in this process.

There is evidence that mTECsLo serve as precursors of mTECsHi in the embryonic thymus. Nevertheless, situtation changes after birth, where only part of mTECsLo pool represents immature mTECsHi reservoir and another part is constituted by mature mTECs which are specialized for expression of chemokine CCL21, discussed above. Further subset of mTECsLo pool is formed by terminally differentiated cells called Post- Aire mTECs which already downregulated the expression of Aire, MHCII and CD80/CD86.

mTEC progenitor cells
TECs (mTECs and cTECs) originate from the third pharyngeal pouch which is a product of endoderm. Their common origin points to the fact that both mTECs and cTECs rise from one bipotent progenitor. This notion was confirmed by several studies of embryonic thymus and was further developed by finding that these bipotent progenitors express cTEC markers. Nevertheless, another sources document existence of mTEC unipotent progenitors that express claudin 3 and 4 (Cld3/4). These two opposite findings were interfaced by observation of unipotent mTEC progenitors in the postnatal thymus that previously expressed cTEC markers and concurrently express Cld3/4. On the other hand, several other studies describe appeareance of bipotent progenitors in postnatal thymus. Thus, embryonic as well as postnatal thymus might shelter both bipotent TEC or unipotent mTEC progenitors.

Similarly as Aire expression, mTECs development is highly dependent on NF- kappa B signaling pathway.